Guillaume Carmona is a highly experienced professional in the field of preclinical product development. With a background in life sciences, Guillaume has held various positions in reputable companies such as Avenge Bio, Sigilon Therapeutics, and Massachusetts Institute of Technology. Additionally, Guillaume has conducted research on cancer, metastasis, integrin trafficking, and angiogenesis during their academic and postdoctoral studies.
Sign up to view 0 direct reports
Get started